COLO B Coloplast A/S Class B

Share buy-back week 10/2018

Share buy-back week 10/2018

Announcement             

12 March 2018

Coloplast – transactions in connection with share buy-back programme

As mentioned in Announcement No. 3/2018 Coloplast has initiated the first part of the share buy-back programme totalling up to DKK 1bn. This part of the programme of DKK500m is expected to take place from 26 February, 2018 to 25 August, 2018.

The buy-back programme will be structured in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and Regulation 2016/1052, also referred to as the "Safe Harbour" rules, which ensure that the company is protected against violation of insider legislation in connection with the buyback programme.

The following transactions have been executed during the period 5 – 9 March 2018:

DateNumber of sharesBuying priceAmount DKK
5 March 2018  8,910509.044,535,544.62
6 March 2018  17,066509.258,690,833.19
7 March 2018  10,387506.315,259,048.20
8 March 2018  14,540513.857,471,363.01
9 March 2018  13,410516.696,928,769.99
Accumulated until now under the programme  133,455 514.1968,621,801.65

Henceforth, Coloplast owns 3,684,183 treasury B shares of DKK 1 equal to 1.71% of the company’s total share capital.

An overview showing the transaction data for the period 5 to 9 March is enclosed.

Kind regards,

Investor Relations

Coloplast A/S

Tel.



For further information, please contact

Investors and analysts                                             

Ellen Bjurgert

Director, Investor Relations

Tel. /

Email:

Rasmus Sørensen

Sr. Manager, Investor Relations

Tel. /

Email:

                                                                                       

Press and the media                                                  

Lina Danstrup

Sr. Media Relations Manager

Tel. 4911 2607

Email:

This announcement is available in a Danish and an English language version. In the event of discrepancies, the Danish version shall prevail.

Coloplast develops products and services that make life easier for people with very personal and private medical conditions. Working closely with the people who use our products, we create solutions that are sensitive to their special needs. We call this intimate healthcare.

Our business includes ostomy care, urology and continence care and wound and skin care. We operate globally and employ about 11,000 people.

The Coloplast logo is a registered trademark of Coloplast A/S. © 2018-03 All rights reserved Coloplast A/S, 3050 Humlebæk, Denmark.

EN
12/03/2018

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Coloplast A/S Class B

 PRESS RELEASE

Coloplast A/S - Opdateret finanskalender 2025-26

Coloplast A/S - Opdateret finanskalender 2025-26 Venligst se vedlagte pdf.  Opdatering af datoer i finanskalenderen Coloplast har opdateret datoerne i selskabets finanskalender vedrørende offentliggørelsen af årsregnskabet for 2025/26 samt afholdelsen af den ordinære generalforsamling 2026. De opdaterede datoer er som følger: Årsregnskabsmeddelelse for 2025/26 og Årsrapport 2025/26: ændret fra 5. november 2026 til 3. november 2026Ordinær generalforsamling 2026: ændret fra 3. december 2026 til 1. december 2026 For yderligere information og kalenderinvitationer til kommende beg...

 PRESS RELEASE

Coloplast A/S - Updated Financial Calendar 2025-26

Coloplast A/S - Updated Financial Calendar 2025-26 Please see enclosed pdf. Update to Financial Calendar Dates Coloplast has updated the dates in its financial calendar for the publication of the FY Financial Statements 2025/26 and the Annual General Meeting 2026.  The updated dates are as follows: Financial Statements for the full year 2025/26 and Annual Report 2025/26: changed from November 5, 2026 to November 3, 2026Annual General Meeting 2026: changed from December 3, 2026 to December 1, 2026 For more information and calendar invitations for upcoming events, please visit:   Kind...

ABGSC Healthcare Research ... (+2)
  • ABGSC Healthcare Research
  • Morten Larsen

ResearchPool Subscriptions

Get the most out of your insights

Get in touch